Professor, Internal Medicine, University of Arkansas COM
Cardiology
Dr. Barry F. Uretsky, MD
|
|
Give Review
Barry Uretsky is an expert in the field of Cardiology. He studied medicine at Temple University School of Medicine. He received awards:"Fellow (FACC)". Barry F. Uretsky is a published doctor. He has 100 publications published. The most current publication "Utility of Frequency Domain Optical Coherence Tomographic Evaluation of Angiographically Optimized Stented Lesions." He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Utility of Frequency Domain Optical Coherence Tomographic Evaluation of Angiographically Optimized Stented Lesions.
- How to improve your "STAR quality".
- Optimizing selection of antithrombotic therapy in patients requiring PCI and long term anticoagulation.
- Modified dual guide catheter ("ping-pong") technique to treat left internal mammary Artery graft perforation.
- Developments in Coronary chronic total occlusion percutaneous Coronary interventions: 2014 state-of-the-art update.
- Regadenoson for FFR: Time to say good-bye to adenosine?
- "Tele-Mentoring" an Interventional Procedure Using a Wearable Computer: First-in-Man.
- Conversations in Cardiology: Bridging antiplatelet therapy before surgery.
- Rebuttal for letter-to-the-editor: Change in donor Artery fractional flow reserve after recanalization of a chronic total occlusion - not as impressive as some might h...
- Outcomes of percutaneous Coronary intervention of chronic total saphenous vein graft occlusions in the contemporary era.
- Safety and efficacy of device closure for patent foramen ovale for secondary prevention of neurological events: Comprehensive systematic review and meta-analysis of ra...
- Rebuttal: Response to letter by fan and colleagues regarding "impact on fractional flow reserve of donor Artery by chronic total obstruction revascularization"
- The myocardium supplied by a Chronic total occlusion is a persistently ischemic zone.
- Reversal of ischemia of donor Artery myocardium after recanalization of a chronic total occlusion.
- Pathophysiology and prognosis: The curious case of the periprocedural Myocardial infarction.
- Prolonged high-pressure is required for optimal stent deployment as assessed by optical coherence tomography.
- Conversation in cardiology: Should FFR and IVUS be counted as pci?
- Symptomatic right ventricular ischemia secondary to a critical stenosis in a nondominant right Coronary artery.
- Left Atrial inflow and outflow obstruction as a complication of retrograde approach for chronic total occlusion: Report of a case and literature review of left Atrial ...
- The risk of adverse cardiac and bleeding events following noncardiac surgery relative to antiplatelet therapy in patients with prior percutaneous Coronary intervention.
- Intervention in the occluded vein graft: with high risk can come great reward. Review of techniques with case examples.
- Normal fractional flow reserve with a critical stenosis supplying viable myocardium.
- Prasugrel-Induced Rash (July/August).
- Substrate for complications.
- Atresia of the left internal mammary Artery graft following percutaneous intervention of the left main.
- Retrograde fractional flow reserve and recanalization of a Chronic total occlusion of a saphenous venous graft.
- Utility of fractional flow reserve to determine treatment after recent large Myocardial infarction with severe left ventricular dysfunction.
- The Value of recanalizing a Chronic total occlusion.
- Computed tomography and angiography of left ventricular diverticulum.
- ST-Elevation myocardial infarction as a complication of retrograde Chronic total occlusion recanalization.
- Determining the significance of side branch lesion during bifurcation stenting.
- Heart protection by combination therapy with esmolol and milrinone at late-ischemia and early reperfusion.
- Should serum troponin after PCI be used to predict long-term outcomes?.......Not quite yet!
- Outcomes After Carotid Artery Stenting and Endarterectomy in the Medicare Population.
- Quality assessment and improvement in interventional cardiology: A position statement of the society of cardiovascular angiography and interventions, Part II: Public r...
- Letter by Uretsky Regarding Article, "Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-...
- Bare-metal stent thrombosis after noncardiac surgery greater than 10 years after stent implantation.
- Quality assessment and improvement in interventional cardiology: A position statement of the Society of Cardiovascular Angiography and Interventions, part 1: Standards...
- The effect of CTO recanalization on FFR of the donor Artery.
- Effect of chronic Angiotensin converting enzyme inhibitor therapy on myocardial injury in patients undergoing percutaneous Coronary interventions.
- Does mini-STAR equal mega-success?
- Pseudoaneurysm of the mitral-Aortic intervalvular fibrosa (MAIVF): A comprehensive review.
- Primary PCI for the "late presenter" with STEMI: how late is too late?
- IIb or not IIb? Toward a rational application of left main stenting.
- Cardiac calcitonin gene-related peptide and left ventricular hypertrophy in the cardiac allograft.
- Retrograde approach to a totally occluded right Coronary artery via a septal perforator artery: the tale of a long and winding wire.
- Time for left main stenting in patients with LV dysfunction? Proceed with caution!
- Retrograde recanalization of a Chronic total occlusion of a saphenous vein graft.
- "Drip-and-ship," "Stay-and-pray," "Freight-and-wait (and possibly inflate)" or simply opening the window wider?: Decision-making regardin...
- Optimizing bifurcation stenting: the SPRINT technique.
- Treating the left main bifurcation lesion: the "three stent solution".
- Can I be a star (or at least perform one)?
- Distal myocardial protection with intraCoronary beta blocker when added to a Gp IIb/IIIa platelet receptor blocker during percutaneous Coronary intervention improves c...
- Predictors of mortality from pump failure and sudden cardiac death in patients with systolic Heart failure and left ventricular dyssynchrony: results of the CARE-HF tr...
- Phosphorylation of 5-lipoxygenase at ser523 by protein kinase A determines whether pioglitazone and atorvastatin induce proinflammatory leukotriene B4 or anti-inflamma...
- Treatment of Chronic total occlusion by retrograde passage of stents through an epicardial collateral vessel.
- Advancing backward: a word of caution.
- The role of eNOS, iNOS, and NF-kappaB in upregulation and activation of cyclooxygenase-2 and infarct size reduction by atorvastatin.
- Thrombus aspiration during primary percutaneous Coronary intervention.
- Survival advantage in Medicare patients receiving drug-eluting stents compared with bare metal stents: real or artefactual?
- Pretreatment with high-dose statin, but not low-dose statin, ezetimibe, or the combination of low-dose statin and ezetimibe, limits infarct size in the rat.
- Task force 13: training in advanced cardiovascular imaging (computed tomography).
- The cardioprotective effect of a statin and cilostazol combination: relationship to Akt and endothelial nitric oxide synthase activation.
- The central role of adenosine in statin-induced ERK1/2, Akt, and eNOS phosphorylation.
- Meta-analysis of published reports on the effect of statin treatment before percutaneous Coronary intervention on periprocedural myonecrosis.
- Anti-platelet and anti-thrombotic approaches in patients undergoing percutaneous Coronary intervention.
- Pretreatment with statins may reduce cardiovascular morbidity and mortality after elective surgery and percutaneous Coronary intervention: clinical evidence and possib...
- Activation of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) by atorvastatin is mediated by 15-deoxy-delta-12,14-PGJ2.
- Mediating delta-opioid-initiated Heart protection via the beta2-adrenergic receptor: role of the intrinsic cardiac adrenergic cell.
- Enhanced cardioprotection against ischemia-reperfusion injury with a dipyridamole and low-dose atorvastatin combination.
- Time to reperfusion in Acute myocardial infarction. It is time to reduce it!
- Aspirin before reperfusion blunts the infarct size limiting effect of atorvastatin.
- The cycloxygenase 2 (COX-2) story: it's time to explain, not inflame.
- SCAI: Going global.
- Aspirin augments 15-epi-lipoxin A4 production by lipopolysaccharide, but blocks the pioglitazone and atorvastatin induction of 15-epi-lipoxin A4 in the rat Heart.
- Grade 3 ischemia on admission electrocardiogram and chest pain duration predict failure of ST-segment resolution after primary percutaneous Coronary intervention for a...
- Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures.
- Infective Coronary aneurysms: a complication of percutaneous Coronary intervention.
- Implementation and application of a continuous quality improvement (CQI) program for the cardiac catheterization laboratory: one institution's 10-year experience.
- Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and possible interactions.
- Augmentation of Myocardial production of 15-epi-lipoxin-a4 by pioglitazone and atorvastatin in the rat.
- Heart failure improvement with CoQ10, Hawthorn, and magnesium in a patient scheduled for cardiac resynchronization-defibrillator therapy: a case study.
- Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2.
- Statins are associated with lower risk of gastrointestinal bleeding in patients with unstable Coronary syndromes: analysis of the Orbofiban in Patients with Unstable c...
- Entrapment of a cerebral embolic protection device--a case report.
- Enhanced cardioprotection against ischemia-reperfusion injury with combining sildenafil with low-dose atorvastatin.
- Vineberg procedure for inadvertent injury to anomalous left anterior descending Artery during tetralogy of fallot repair: four decades later.
- Chronic pseudoAneurysm and coarctation of the aorta: a rare delayed complication of trauma.
- Gadodiamide-based Coronary angiography in a patient with severe renal insufficiency.
- The 2005 National Meeting at Ponte Vedra: a great meeting and a very good sign for the future.
- Society planning and consensus-building in 2005: where have we been? Where should we go next?
- Benefits, unresolved questions, and technical issues of cardiac resynchronization therapy for Heart failure.
- Carvedilol improves myocardial contractility compared with metoprolol in patients with Chronic hibernating myocardium after revascularization.
- "The year of the Carotid": what I've learned (so far...).
- Small was good, will big be better?
- Administration of vascular endothelial growth factor adjunctive to fetal cardiomyocyte transplantation and improvement of cardiac function in the rat model.
- Monocyte chemoattractant protein 1-induced monocyte infiltration produces angiogenesis but not arteriogenesis in Chronically infarcted myocardium.
- The renal patient with Coronary artery disease: current concepts and dilemmas.
- Effect of rosiglitazone on restenosis after Coronary stenting in patients with type 2 diabetes.
Schools
Temple University
Boston City Hospital
Boston University Med CtrUniv Hp
Procedures Preformed
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardioverter-Defibrillator or Pacemaker Insertion, Removal or Repair
- Coronary Angioplasty, Atherectomy and Stent
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- CHAMPVA
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- GEHA
- Choice Care PPO
- Mail Handlers Benefit Plan (MHBP)
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Mutual of Omaha
- Qualchoice PPO
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Fellow (FACC)
Education
-
Boston University Medical Center -
Temple University School of Medicine
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1316009731 |
| Last Name Of The Provider | URETSKY |
| First Name Of The Provider | BARRY |
| View All |
Similar Doctors
|
|
Dr. David R. Hundley, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David Jones, MD |
|
Dr. Mangaraju N. Chakka, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Donald F. Meacham, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lonnie E. Harrison, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Trace Garner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph Bissett, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian B. Norris, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Randell B. Minton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David L. Rutlen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Ahmed A. Almomani, MB BS
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sandeep Singla, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bal K. Singh, MD |